Categories: News

UMass Medical School and AEYE Health leverage AI to help family doctors screen and refer patients with eye conditions to specialists

NEW YORK, March 30, 2021 /PRNewswire/ — AEYE Health and UMass Medical School, in collaboration with UMass Memorial Health Care, are developing a system which enables family doctors to screen patients for various retinal conditions and enable timely referrals to specialists.

As part of this effort, AEYE Health’s AI will be incorporated into UMass’s patient treatment protocols to automatically diagnose various retinal and systemic diseases from digital fundus images obtained at primary care clinics.

According to Shlomit Schaal, MD, PhD, MHCM, Professor and Chair of UMass Medical School’s Department of Ophthalmology & Visual Sciences “There are multiple eye diseases that can be detected and treated early to prevent vision loss. Therefore, leveraging the power of AI to promote adherence to screening protocols is nothing less than sight saving. Early detection and intervention are crucial in preventing severe vision loss.”

Zack Dvey-Aharon, Ph.D., Co-founder and CEO of AEYE Health said, “We are excited to work with UMass, with the support of the BIRD Foundation, to create a unique system that makes retinal screening accessible and ensures no patient is left behind.”

Family physicians know that diabetes mellitus is the leading cause of blindness. “Unfortunately, the challenges of managing diabetes can make it difficult for patients to see specialists to screen for problems that the patient doesn’t notice until too late,” James Ledwith, MD, PI and Assistant Professor of Family Medicine and Community Health at UMass. “The use of a compact retinal camera and AEYE Health software in our practice will assure that every patient can be screened during one of their routine visits each year. We anticipate that physicians using this technology are expected to improve screening performance from 30-35% to 80% or more. When one out of four patients with diabetes has retinopathy, primary care screening will result in new vision-saving intervention several times a year.”

The partnership is supported by a BIRD Foundation grant which was announced last July.

About UMASS Medical School and UMASS Memorial Health

UMass Medical School was founded in 1962 with the mission to advance the health and wellness of our diverse communities throughout Massachusetts and across the world by leading and innovating in education, research, health care delivery and public service. It is consistently ranked by U.S. News & World Report as one of the leading medical schools in the nation for primary care education. It is also Massachusetts’s first and only public academic health sciences center.

UMass Memorial Health Care is the largest health care system in Central Massachusetts and the clinical partner of UMass Medical School. UMass Memorial Health Care employs 1,700 physicians on active medical staff, 3,000 registered nurses, and over 14,000 total employees.

Visit www.aeyehealth.com to learn more about AEYE Health.

For more information please contact:
Zack Dvey-Aharon, Ph.D., CEO, AEYE Health LLC, zack@aeyehealth.com

View original content:http://www.prnewswire.com/news-releases/umass-medical-school-and-aeye-health-leverage-ai-to-help-family-doctors-screen-and-refer-patients-with-eye-conditions-to-specialists-301258509.html

SOURCE AEYE Health

Staff

Recent Posts

Vent Creativity Appoints Paul Abrams as Vice President of Sales to Lead Commercial Growth

NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…

10 hours ago

AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai

AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…

10 hours ago

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

1 day ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

1 day ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

1 day ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

1 day ago